Listed on GrantGunner. Last checked 16 Oct 2026.
About this grant
This subsidy call targets Dutch companies, research and knowledge institutions for building and/or upgrading shared infrastructure facilities for the development, scaling, and production of (innovative) medicines in the Netherlands. The total budget amounts to 23.3 million euros, with a maximum of 5 million euros per application and mandatory co-financing of 50%. A condition is that the infrastructure must be made available for at least 50% of the available time at market-conforming prices for shared use by start-ups, scale-ups, and academic research groups.
Who can apply
Public or private legal entities established in the Netherlands, including companies, research and knowledge institutions.